Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
RNTX holding history
Rein Therapeutics, Inc. in every 13F filed by Prosight Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RNTX overviewAll 13F holders of RNTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,100,000
- Value
- $1.14M
- % of portfolio
- 0.2%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,100,000 | $1.14M | 0.2% | +688,400+167.2% | Added | Holders |
| Q1 2026 | 411,600 | $535.1K | 0.1% | −31,000−7.0% | Reduced | Holders |
| Q4 2025 | 442,600 | $513.4K | 0.1% | −125,298−22.1% | Reduced | Holders |
| Q3 2025 | 567,898 | $650.2K | 0.2% | +139,979+32.7% | Added | Holders |
| Q2 2025 | 427,919 | $599.1K | 0.1% | −2,081−0.5% | Reduced | Holders |
| Q1 2025 | 430,000 | $761.1K | 0.3% | +25,021+6.2% | Added | Holders |
| Q4 2024 | 404,979 | $931.5K | 0.3% | +32,822+8.8% | Added | Holders |
| Q3 2024 | 372,157 | $1.32M | 0.3% | +107,157+40.4% | Added | Holders |
| Q2 2024 | 265,000 | $734.0K | 0.2% | +265,000 | New | Holders |